James E. Crowe

37.9k total citations · 8 hit papers
417 papers, 19.2k citations indexed

About

James E. Crowe is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, James E. Crowe has authored 417 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Epidemiology, 192 papers in Infectious Diseases and 96 papers in Immunology. Recurrent topics in James E. Crowe's work include Respiratory viral infections research (127 papers), Viral Infections and Vectors (82 papers) and Viral gastroenteritis research and epidemiology (73 papers). James E. Crowe is often cited by papers focused on Respiratory viral infections research (127 papers), Viral Infections and Vectors (82 papers) and Viral gastroenteritis research and epidemiology (73 papers). James E. Crowe collaborates with scholars based in United States, France and Germany. James E. Crowe's co-authors include John V. Williams, Michael Diamond, Brian R. Murphy, Jens C. Krause, Kathryn M. Edwards, Ian A. Wilson, Nurgun Kose, Peter F. Wright, Sharon J. Tollefson and Scott A. Smith and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

James E. Crowe

403 papers receiving 18.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children

2004 703 citations James E. Crowe et al. profile →
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Pavlo Gilchuk, Seth J. Zost et al. profile →
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

2010 485 citations Rui Xu, Damian C. Ekiert et al. Science profile →
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

2022 423 citations Seth J. Zost, James E. Crowe et al. profile →
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

2016 295 citations Gopal Sapparapu, Nurgun Kose et al. profile →
Mxra8 is a receptor for multiple arthritogenic alphaviruses

2018 265 citations Arthur S. Kim, Julie M. Fox et al. profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Pavlo Gilchuk et al. Cell profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers

Countries citing papers authored by James E. Crowe

Since Specialization

Citations

This map shows the geographic impact of James E. Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Crowe more than expected).

Fields of papers citing papers by James E. Crowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Crowe. The network helps show where James E. Crowe may publish in the future.

Co-authorship network of co-authors of James E. Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Crowe. A scholar is included among the top collaborators of James E. Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Crowe. James E. Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine 2025 ·Journal of Clinical Investigation ·Chandru Subramani, Michelle Meyer, (unknown), (unknown), Haiping Hao, James E. Crowe, Vsevolod L. Popov, Harshwardhan M. Thaker, Sunny Himansu, Andrea Carfı́, Alexander Bukreyev	0
2	Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses 2025 ·Nature Communications ·Michelle Meyer, Bronwyn M. Gunn, Colette Pietzsch, Chandru Subramani, (unknown), (unknown), (unknown), Erica Ollmann Saphire, James E. Crowe, Galit Alter, Sunny Himansu, Andrea Carfı́, Alexander Bukreyev	1
3	Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques 2024 ·Journal of Virology ·Joseph P. Nkolola, David Hope, (unknown), (unknown), Malika Aïd, Deborah Weiss, (unknown), Hanné Andersen, Mark G. Lewis, Lauren E. Williamson, (unknown), James E. Crowe, Dan H. Barouch	0
4	Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis 2024 ·JCI Insight ·(unknown), (unknown), Cynthia M. McMillen, (unknown), (unknown), (unknown), (unknown), (unknown), Douglas S. Reed, James E. Crowe, Amy L. Hartman	1
5	Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody 2023 ·Nature Microbiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), James E. Crowe, Thomas A. Bowden	9
6	Convergent antibody responses are associated with broad neutralization of hepatitis C virus 2023 ·Frontiers in Immunology ·Nicole Skinner, (unknown), (unknown), (unknown), (unknown), Srinivasan Yegnasubramanian, Kornel E. Schuebel, Jennifer Meyers, Anuj Gupta, Sarah J. Wheelan, Andrea L. Cox, James E. Crowe, Stuart C. Ray, Justin R. Bailey	6
7	Computational epitope mapping of class I fusion proteins using low complexity supervised learning methods 2022 ·PLoS Computational Biology ·(unknown), James E. Crowe, Jens Meiler	2
8	Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking 2022 ·Nature Biotechnology ·Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, (unknown), Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev	27
9	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection breakdown → 2021 ·Cell ·Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C. M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael Diamond	183
10	Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions 2020 ·Proceedings of the National Academy of Sciences ·Nina G. Bozhanova, Amandeep K. Sangha, Alexander M. Sevy, Pavlo Gilchuk, Kai Huang, Rachel S. Nargi, Joseph X. Reidy, Andrew Trivette, Robert H. Carnahan, Alexander Bukreyev, James E. Crowe, Jens Meiler	9
11	Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease 2020 ·PLoS Pathogens ·(unknown), Julie M. Fox, Nurgun Kose, Arthur S. Kim, (unknown), Robin Bombardi, Robert H. Carnahan, James C. Slaughter, Thomas E. Morrison, Michael Diamond, James E. Crowe	20
12	Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection 2020 ·Cell ·Lauren E. Williamson, Theron Gilliland, Pramod Kumar Yadav, Elad Binshtein, Robin Bombardi, Nurgun Kose, Rachel S. Nargi, Rachel E. Sutton, (unknown), Erica Armstrong, Robert H. Carnahan, Lauren Walker, Arthur S. Kim, Julie M. Fox, Michael Diamond, Melanie D. Ohi, William B. Klimstra, James E. Crowe	27
13	Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires 2020 ·mAbs ·(unknown), Cinque Soto, James E. Crowe, Jens Meiler	11
14	Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance 2019 ·Journal of Clinical Investigation ·(unknown), Guido Massaccesi, Andrew I. Flyak, Madeleine C. Mankowski, (unknown), William O. Osburn, Stuart C. Ray, Andrea L. Cox, James E. Crowe, Justin R. Bailey	36
15	Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins 2018 ·PLoS Pathogens ·Jarrod J. Mousa, Elad Binshtein, Stacey Human, Rachel H. Fong, Gabriela Alvarado, Benjamin J. Doranz, Martin L. Moore, Melanie D. Ohi, James E. Crowe	29
16	Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination 2016 ·Journal of Virology ·Usha K. Nivarthi, Nurgun Kose, Gopal Sapparapu, Douglas G. Widman, Emily N. Gallichotte, Jennifer M. Pfaff, Benjamin J. Doranz, Daniela Weiskopf, Alessandro Sette, Anna P. Durbin, (unknown), Ralph S. Baric, James E. Crowe, Aravinda M. de Silva	39
17	Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1 2016 ·Journal of Virology ·William B. Messer, Boyd L. Yount, Scott R. Royal, Ruklanthi de Alwis, Douglas G. Widman, Scott A. Smith, James E. Crowe, Jennifer M. Pfaff, Kristen M. Kahle, Benjamin J. Doranz, Kristie D. Ibarra, Eva Harris, Aravinda M. de Silva, Ralph S. Baric	26
18	A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses 2016 ·Science ·Anna Z. Wec, Elisabeth K. Nyakatura, Andrew S. Herbert, Katie A. Howell, Frederick W. Holtsberg, Russell R. Bakken, Eva Mittler, John R. Christin, Sergey Shulenin, Rohit K. Jangra, Sushma Bharrhan, Ana I. Kuehne, Zachary A. Bornholdt, Andrew I. Flyak, Erica Ollmann Saphire, James E. Crowe, M. Javad Aman, John M. Dye, Jonathan R. Lai, Kartik Chandran	80
19	Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers 2015 ·Science ·G. Fibriansah, Kristie D. Ibarra, Thiam‐Seng Ng, Scott A. Smith, Joanne L. Tan, Xin-Ni Lim, Justin S. G. Ooi, V.A. Kostyuchenko, Jiaqi Wang, Aravinda M. de Silva, Eva Harris, James E. Crowe, Shee‐Mei Lok	176
20	Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus breakdown → 2010 ·Science ·Rui Xu, Damian C. Ekiert, Jens C. Krause, Rong Hai, James E. Crowe, Ian A. Wilson	485

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact